(Q34131414)

31 July 2017

title

Nicotine and bupropion share a similar discriminative stimulus effect (English)

1 reference

31 July 2017

0 references

Richard Young

1

1 reference

31 July 2017

Richard A Glennon

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

European Journal of Pharmacology

31 July 2017

published in

1 reference

31 July 2017

volume

443

1 reference

31 July 2017

issue

1-3

1 reference

31 July 2017

page(s)

113-118

1 reference

Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Bupropion: a new treatment for smokers. Nicotine replacement treatment should also be available on the NHS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

7 January 2021

Bupropion hydrochloride.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Psychoses associated with bupropion treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Bupropion for smokers. Drug is almost identical in structure to diethylpropion, a controlled drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

A comparison of sustained-release bupropion and placebo for smoking cessation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Stimulus properties of antidepressants in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Nicotine cue in rats: effects of central administration of ganglion-blocking drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Mecamylamine increases nicotine preference and attenuates nicotine discrimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Nicotine as a Discriminative Stimulus: A Neurobiobehavioral Approach to Studying Central Cholinergic Mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Antagonism of stimulus properties of nicotine by dihydro-beta-erythroidine (DHbetaE) in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Regulation of dopamine receptors by bupropion: comparison with antidepressants and CNS stimulants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Pharmacological significance of the species differences in bupropion metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901554-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(02)01554-6

1 reference

31 July 2017

1 reference